
Pharmaceutical Executive
SAS’s Brad Sitler talks about the importance of incremental sales, customer proximity, and anticipating a compensation model based on health outcomes

Pharmaceutical Executive
SAS’s Brad Sitler talks about the importance of incremental sales, customer proximity, and anticipating a compensation model based on health outcomes

Pharmaceutical Executive
Biotechs in Colorado, US, are enjoying a windfall of funding from Venture Capitalists who have to date invested $66.

Pharmaceutical Executive
A couple of years ago I spoke at a Life Sciences Forum organized by Oracle. The audience was 100-percent life science and IT professionals, but I spoke about the magazine business.

Pharmaceutical Executive
The Supreme Court will open up deliberations on the constitutionality of three important parts of healthcare reform (HCR) this month

Pharmaceutical Executive
Leading in Emerging Markets

PE Emedia Rates 2012

Pharmaceutical Executive
Pharm Exec's latest EAB meeting offered a frank exchange on this magazine's digital future.

Pharmaceutical Executive
GlaxoSmithKline is recalling 394,230 bottles containing its antihypertensive drug DynaCirc CR (isradipine) controlled-release tablets, according to a Feb. 22, 2012, FDA enforcement report

Pharmaceutical Executive
In 1983-with the help of Abbey Meyers and the drive she had to help her son (more on that here)-the Orphan Drug Act was passed to incentivize pharma to step up and play an active role in drug development for the 30 million children and adults in the U.S.

Pharmaceutical Executive
With an all-important FDA decision on carfilzomib scheduled for July 27, Onyx hopes to graduate to the next stage of commercial success. For a feature-length profile of Onyx and CEO Tony Coles

Pharmaceutical Executive
Publicis Healthcare continues its expansion into Asia with this week’s announcement of its acquisition of U-Link Business Solutions (UBS), one of China’s leading agencies specializing in healthcare communications.

Pharmaceutical Executive
A new collaboration will move FDA closer to predicting adverse events – before they happen – as part of the regulatory process

Pharmaceutical Executive
All-told the Mayo Clinic’s recent pilot study on clinical trial patient recruitment using social media and online networks not only helped researchers assemble large and demographically diverse patient groups more quickly, but also less expensively than they could through other means

Pharmaceutical Executive
William Looney’s posting for this blog, “Calculating the Cost of R&D: Defending Tufts Research” (January 11, 2012), raises a number of interesting and important points.

Pharmaceutical Executive
A report released on Feb. 8, 2012 from the California Healthcare Institute, BayBio and PwC shows that the shrinking economy, changes in investment strategies, and pressures on the pharmaceutical market have put the brakes on one of the US’s most robust biotechnology centers

Pharmaceutical Executive

Pharmaceutical Executive
Following the premise that good news needs to be shared, Pharm Exec is proud to announce that one of our sister Advanstar publications, Medical Economics, has been selected as Media Brand of the Year by Medical Marketing and Media (MM&M) magazine.

Pharmaceutical Executive
Of the 399 senior executives in the life sciences industry surveyed by the Economist Intelligence Unit (EIU) recently, 64% of respondents said that demonstrating value is a key challenge facing their business. The major issue, most agree, is that stakeholders have different perceptions of what value is.

Pharmaceutical Executive
David Torstensson, Senior Consultant, Pugatch Consilium, considers what the London Declaration on Neglected Tropical Diseases reveals about research and development efforts into neglected and tropical diseases.


Pharmaceutical Executive
At the digital marketing-focused ePharma Summit in New York this week, many of the problems and frustrations related to the “big three” – Facebook, Twitter and YouTube – were hashed out for umpteenth time.

Pharmaceutical Executive
The Healthcare Businesswomen’s Association (HBA) has announced that its 2012 Woman of the Year (WOTY) is Carolyn Buck Luce, global pharmaceutical sector leader at Ernst & Young.

Pharmaceutical Executive
Allergan CEO David Pyott is bullish on Botox’s potential as a salve for chronic migraine. He’s also betting on a next-gen dihydroergotamine (DHE) – Levadex – from MAP Pharmaceuticals.

Pharmaceutical Executive
In December 2011, the President’s Bioethics Commission released its “Moral Science: Protecting Participants in Human Subjects Research“

Pharmaceutical Executive
Brand of the Year : Abbott's Humira

Pharmaceutical Executive
William Looney looks at the three P’s of effectiveness research: PCORI, Priorities, and Politics

Pharmaceutical Executive
Personalized medicine, which targets individualized treatment and care based on personal and genetic variations, holds much promise for the pharmaceutical industry.

Pharmaceutical Executive
New pharma supply chains, where chill control and traceability challenges will be far more critical, will emerge over the next decade, So it’s time, argues Julian Mosquera, for the industry to upgrade its capabilities.

Pharmaceutical Executive
Even though Roche-owned Genentech wasn’t required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway.

Pharmaceutical Executive
One of the few positive notes struck in this week’s 30th Annual J.P. Morgan Healthcare Conference (held in San Francisco) was the announcement by Kevin Willsey, J.P. Morgan’s co-head of investment banking for North America, that the U.S. economy would grow 2.5 percent in 2012